IRIS UniCatt

Tolusso, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.885
EU - Europa 4.494
AS - Asia 4.215
SA - Sud America 849
Continente sconosciuto - Info sul continente non disponibili 226
AF - Africa 140
OC - Oceania 8
AN - Antartide 2
Totale 16.819
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.690
SG - Singapore 1.952
CN - Cina 995
DE - Germania 925
IT - Italia 894
BR - Brasile 688
SE - Svezia 597
PL - Polonia 530
FR - Francia 488
VN - Vietnam 375
GB - Regno Unito 213
IE - Irlanda 180
UA - Ucraina 169
IN - India 168
FI - Finlandia 148
HK - Hong Kong 126
ID - Indonesia 120
BD - Bangladesh 116
CA - Canada 90
JP - Giappone 88
RU - Federazione Russa 82
AR - Argentina 65
MX - Messico 58
TR - Turchia 55
NL - Olanda 53
BE - Belgio 49
IQ - Iraq 43
ZA - Sudafrica 39
KR - Corea 31
AT - Austria 29
CI - Costa d'Avorio 27
ES - Italia 25
VE - Venezuela 23
MA - Marocco 18
CH - Svizzera 16
CO - Colombia 16
CZ - Repubblica Ceca 16
EC - Ecuador 16
PK - Pakistan 16
SA - Arabia Saudita 16
IR - Iran 15
LT - Lituania 15
KE - Kenya 13
UZ - Uzbekistan 12
PE - Perù 11
TN - Tunisia 11
CR - Costa Rica 10
PH - Filippine 10
IL - Israele 9
JO - Giordania 9
PY - Paraguay 9
RO - Romania 9
JM - Giamaica 8
UY - Uruguay 8
AU - Australia 7
GR - Grecia 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
CL - Cile 6
DZ - Algeria 6
EU - Europa 6
NP - Nepal 6
PT - Portogallo 6
EE - Estonia 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
DK - Danimarca 4
EG - Egitto 4
HN - Honduras 4
HU - Ungheria 4
KH - Cambogia 4
LK - Sri Lanka 4
NG - Nigeria 4
SN - Senegal 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AM - Armenia 3
AO - Angola 3
AZ - Azerbaigian 3
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
KG - Kirghizistan 3
MY - Malesia 3
PA - Panama 3
PR - Porto Rico 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AQ - Antartide 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GT - Guatemala 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
Totale 16.571
Salva come PNG Salva come JPEG
Città #
Singapore 1.097
Chandler 640
Ashburn 621
San Jose 523
Warsaw 480
New York 200
Beijing 197
Rome 193
Fairfield 191
Ann Arbor 165
Dublin 165
Dearborn 150
Los Angeles 142
The Dalles 127
Wilmington 126
Ho Chi Minh City 125
Woodbridge 120
Dallas 116
Milan 115
Seattle 115
Hong Kong 112
Jakarta 110
Jacksonville 105
Nanjing 100
Lauterbourg 99
Munich 99
Hanoi 97
Hefei 97
San Mateo 94
Chicago 88
Houston 88
Cattolica 78
Tokyo 76
Frankfurt am Main 74
Boston 67
Helsinki 65
Cambridge 63
São Paulo 62
Bremen 51
Princeton 51
Atlanta 46
Marseille 44
Santa Clara 44
Brussels 43
London 43
Buffalo 39
Council Bluffs 37
Moscow 37
North Bergen 34
Boardman 32
Nürnberg 32
Lawrence 31
Redwood City 30
Izmir 29
Turku 28
Abidjan 27
Pune 27
Seoul 27
Toronto 25
Denver 24
Montreal 24
Nuremberg 24
Orem 24
St Louis 24
Norwalk 23
Phoenix 23
Kent 22
Kraków 22
Tianjin 22
Redmond 21
San Francisco 21
Chennai 20
Kunming 20
Lancaster 20
Mexico City 20
Nanchang 20
Haiphong 19
Paris 19
Amsterdam 18
Baghdad 18
Lappeenranta 18
Shanghai 18
Da Nang 17
Rio de Janeiro 17
Brasília 16
Hangzhou 16
Hebei 16
Johannesburg 16
Mountain View 16
Poplar 16
Brooklyn 15
Jiaxing 14
Leawood 14
Portsmouth 14
Shenyang 14
Stockholm 14
Vienna 14
Busto Arsizio 13
Curitiba 13
Roubaix 13
Totale 8.691
Salva come PNG Salva come JPEG
Nome #
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 496
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 445
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 406
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 352
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 347
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 320
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 308
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 301
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 281
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 268
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 268
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 262
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 243
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 237
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 215
COVID-19 atypical Parsonage-Turner syndrome: a case report 208
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 208
Malnutrition in COVID-19 survivors: prevalence and risk factors 206
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 206
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 202
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 199
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 196
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 194
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 182
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 179
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 176
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 174
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 174
Sarilumab use in severe SARS-CoV-2 pneumonia 170
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 169
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 168
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 167
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 167
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 162
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 161
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 161
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 154
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 150
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 149
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 148
Mitochondria-Derived Vesicles and Inflammatory Profiles of Adults with Long COVID Supplemented with Red Beetroot Juice: Secondary Analysis of a Randomized Controlled Trial 147
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 144
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 143
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 143
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 141
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 140
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 138
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 132
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 132
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 132
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 130
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 130
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 128
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 128
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 127
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 127
Beetroot juice intake positively influenced gut microbiota and inflammation but failed to improve functional outcomes in adults with long COVID: A pilot randomized controlled trial 127
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 127
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 126
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 125
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 124
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 124
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 121
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 121
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 120
null 118
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 118
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 117
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 116
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 115
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 110
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 106
Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve 106
Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role? 106
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 105
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 105
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 105
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis 104
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 103
Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve (Endocrine, (2019), 63, 2, (369-375), 10.1007/s12020-018-1783-1) 102
Weight Loss, The Obesity Paradox in Rheumatoid Arthritis: Is It a Paradox? Comment on the Article by Baker et al 102
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 101
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study 99
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: A case report 99
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study. 98
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 98
Is it necessary to be citrullinated to have restricted clonotypes reacting with Collagen type II? Comment to article "A novel HLA-DRB1*10:01 restricted T cell epitope from citrullinated type II collagen relevant for Rheumatoid Arthritis" 97
The B side of rheumatoid arthritis pathogenesis 94
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 93
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 93
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 92
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 92
Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES 91
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 89
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 87
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 86
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 86
Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs 84
Exploring perinatal mesenchymal stromal cells as a potential therapeutic strategy for rheumatoid arthritis 79
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 79
Totale 15.931
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022796 0 62 38 61 65 29 28 103 41 67 133 169
2022/20231.893 220 239 150 300 117 224 92 140 235 62 63 51
2023/20241.112 42 253 46 64 45 189 81 52 14 78 160 88
2024/20252.397 48 47 176 94 200 91 101 98 357 263 476 446
2025/20266.217 840 224 404 689 931 344 1.002 278 353 399 239 514
2026/2027820 211 609 0 0 0 0 0 0 0 0 0 0
Totale 16.819